At the start this morning, at the Policlinico Umberto I in Rome, the first administration of therapies with monoclonal antibodies on Covid patients who have not yet shown evident symptoms of the disease. The first patient, a 59-year-old man with cardiovascular pathologies and hypertension, received the dose at the ‘Covid Monoclonal Administration Center’ of the Infectious Diseases Department of the Roman Polyclinic, directed by Claudio Mastroianni, and reacted positively.
“The treatment – explains Mastroianni – as for this patient, must take place according to AIFA indications, preferably within 72 hours, and in any case no later than 10 days from the onset of the symptoms of the disease”. To access the Center – remember a note from the Roman hospital – you need a prescription from the family doctor, from that of Uscar or from the emergency room doctor who will be able to access the telephone number and e-mail address dedicated to doctors made available by Hospital.
According to AIFA, Mastroianni underlines, “the population eligible for treatment is represented only by subjects over the age of 12, positive for Sars-CoV-2, not hospitalized, not on oxygen therapy for Covid-19, with mild symptoms -moderate of recent onset, preferably within 72 hours (and in any case no later than 10 days from diagnosis) and presence of at least one of the risk factors (or at least 2 if one of them is over 65 years of age) “.
“The Policlinico Umberto I – declares the general director Fabrizio d’Alba – is one of the first regional principals to have activated this service. The launch of the Monoclonal Administration Center goes to implement the other activities implemented in this second year of the pandemic . Activities which, such as the administration of the vaccine to the approximately 10,000 extremely vulnerable patients followed by the hospital, the expansion of a further 18 Covid intensive care beds with humanization programs, confirm the willingness of our hospital to take care of patients 360 degrees “.